Towards regulatory cellular therapies in solid organ transplantation 著者: Bottomley, MJ, Brook, MO, Shankar, S, Hester, J, Issa, F

Late treatment with autologous expanded regulatory T-cell therapy after alemtuzumab induction is safe and facilitates immunosuppression minimization in living donor renal transplan... 著者: Brook, MO, Hennessy, C, Hester, J, Hammad, S, Alzhrani, A, Rombach, I, Dutton, S, Lombardi, G, Wood, KJ, Friend, P, Harden, PN, Issa, F

Transplantation Without Overimmunosuppression (TWO) study protocol: a phase 2b randomised controlled single-centre trial of regulatory T cell therapy to facilitate immunosuppressio... 著者: Brook, MO, Hester, J, Petchey, W, Rombach, I, Dutton, S, Bottomley, MJ, Black, J, Abdul-Wahab, S, Bushell, A, Lombardi, G, Wood, K, Friend, P, Harden, P, Issa, F

Feasibility, long‐term safety and immune monitoring of regulatory T cell therapy in living donor kidney transplant recipients 著者: Harden, PN, Game, D, Sawitzki, B, Van der Net, J, Hester, J, Bushell, A, Issa, F, Brook, MO, Alzhrani, A, Schlickeiser, S, Scotta, C, Petchey, W, Blancho, G, Tang, Q, Markmann, J, Lechler, RI, Roberts, IR, Friend, P, Hilton, R, Geissler, EK, Wood, KJ, Lombardi, G